$SWAG
Stran & Company, Inc. Stock $swag

$swag Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024027282 Filed on March 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue		$23.34M	$75.89M
YoY Change		-16.48%	28.74%
Cost Of Revenue		$14.60M	$51.01M
YoY Change		0.03%	20.36%
Gross Profit		$8.739M	$24.88M
YoY Change		-34.53%	50.16%
Gross Profit Margin		37.44%	32.78%
Selling, General & Admin		$7.660M	$26.03M
YoY Change		-68.76%	-64.32%
% of Gross Profit		87.65%	104.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$466.2K	$1.506M
YoY Change		140.33%	107.64%
% of Gross Profit		5.34%	6.05%
Operating Expenses		$7.660M	$26.03M
YoY Change		-70.33%	44.01%
Operating Profit		$1.079M	-$1.149M
YoY Change		-108.66%	-23.72%
Interest Expense		$238.2K	$840.0K
YoY Change		-97.73%	-108.62%
% of Operating Profit		22.07%
Other Income/Expense, Net		$61.33K	$375.1K
YoY Change		-103.27%	1236.3%
Pretax Income		$1.379M	$66.51K
YoY Change		-136.02%	-104.5%
Income Tax		$495.4K	$31.45K
% Of Pretax Income		35.93%	47.29%
Net Earnings		$883.3K	$35.06K
YoY Change		-130.31%	-104.5%
Net Earnings / Revenue		3.78%	0.05%
Basic Earnings Per Share			$0.00
Diluted Earnings Per Share		$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	18.61M shares	18.57M shares	18.52M shares
Diluted Shares Outstanding			29.45M shares

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.45M	$18.45M
YoY Change	19.94%	19.94%
Cash & Equivalents	$7.989M
Short-Term Investments	$10.46M	$10.46M
Other Short-Term Assets	$3.528M	$3.528M
YoY Change	38.95%	38.95%
Inventory	$6.639M	$6.639M
Prepaid Expenses
Receivables	$20.47M	$20.47M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$49.09M	$49.09M
YoY Change	1.06%	39.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.857M	$2.857M
YoY Change	185.63%	-84.95%
Goodwill
YoY Change
Intangibles	$9.659M
YoY Change	54.0%
Long-Term Investments
YoY Change
Other Assets	$11.00M
YoY Change	923.76%
Total Long-Term Assets	$12.52M	$12.52M
YoY Change	55.34%	-68.48%
TOTAL ASSETS
Total Short-Term Assets	$49.09M	$49.09M
Total Long-Term Assets	$12.52M	$12.52M
Total Assets	$61.60M	$61.60M
YoY Change	8.79%	-17.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.316M	$4.316M
YoY Change	-77.98%	-77.98%
Accrued Expenses	$3.091M	$3.091M
YoY Change	-74.53%	-74.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.870M	$2.870M
YoY Change	58.58%	58.58%
Total Short-Term Liabilities	$16.67M	$16.67M
YoY Change	19.43%	-68.97%
LONG-TERM LIABILITIES
Long-Term Debt	$4.587M	$4.587M
YoY Change	-92.46%	-92.46%
Other Long-Term Liabilities	$797.6K	$797.6K
YoY Change	-97.58%	-97.58%
Total Long-Term Liabilities	$5.384M	$5.384M
YoY Change	62.86%	-94.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.67M	$16.67M
Total Long-Term Liabilities	$5.384M	$5.384M
Total Liabilities	$22.05M	$22.05M
YoY Change	27.75%	-85.1%
SHAREHOLDERS EQUITY
Retained Earnings	$1.119M
YoY Change	3.24%
Common Stock	$38.43M
YoY Change	2079494.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$39.55M	$39.55M
YoY Change
Total Liabilities & Shareholders Equity	$61.60M	$61.60M
YoY Change	8.79%	-17.79%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$883.3K	$35.06K
YoY Change	-130.31%	-104.5%
Depreciation, Depletion And Amortization	$466.2K	$1.506M
YoY Change	140.33%	107.64%
Cash From Operating Activities	-$985.1K	-$4.365M
YoY Change	-24.28%	80.82%
INVESTING ACTIVITIES
Capital Expenditures	$209.7K	$1.660M
YoY Change	-235.29%	164.98%
Acquisitions
YoY Change
Other Investing Activities	-$44.86K	-$414.9K
YoY Change	-94.36%	-47.88%
Cash From Investing Activities	-$254.6K	-$2.075M
YoY Change	-60.29%	-82.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$50.00K
YoY Change		-101.5%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-215.3K	-825.3K
YoY Change		-71.66%
NET CHANGE
Cash From Operating Activities	-985.1K	-4.365M
Cash From Investing Activities	-254.6K	-2.075M
Cash From Financing Activities	-215.3K	-825.3K
Net Change In Cash	-1.455M	-7.265M
YoY Change	-25.08%	-57.2%
FREE CASH FLOW
Cash From Operating Activities	-$985.1K	-$4.365M
Capital Expenditures	$209.7K	$1.660M
Free Cash Flow	-$1.195M	-$6.025M
YoY Change	4.26%	98.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41038
CY2023	dei	Entity Registrant Name EntityRegistrantName	STRAN & COMPANY, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3297200
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 Heritage Drive
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Quincy
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02171
CY2023	dei	Local Phone Number LocalPhoneNumber	800-833-3309
CY2023	dei	City Area Code CityAreaCode	800
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	13484863.01	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18607329	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	7988803	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	15253756	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	10463799	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	9779355	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	20465564	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14442626	usd
CY2023Q4	strn	Deferred Income Taxes Current DeferredIncomeTaxesCurrent	841000	usd
CY2022Q4	strn	Deferred Income Taxes Current DeferredIncomeTaxesCurrent	841000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6639358	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6867564	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	16800	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	87459	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	952691	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	386884	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1717444	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	910486	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	49085459	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	48569130	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1520933	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1000090	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9659481	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6272205	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1335653	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	784683	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10995134	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7056888	usd
CY2023Q4	us-gaap	Assets Assets	61601526	usd
CY2022Q4	us-gaap	Assets Assets	56626108	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	2870274	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	1809874	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	527548	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	324594	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4316198	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4051657	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2563238	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	608589	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5171479	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	633148	usd
CY2023Q4	strn	Reward Program Liability RewardProgramLiability	875000	usd
CY2022Q4	strn	Reward Program Liability RewardProgramLiability	6000000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	343944	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	365303	usd
CY2022Q4	strn	Note Payable Wildman NotePayableWildman	162358	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16667681	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13955523	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	4586765	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	2845944	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	797558	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	460089	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5384323	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3306033	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18534073	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18534073	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18475521	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18475521	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1854	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1848	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	38429057	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	38279151	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1118611	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1083553	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	39549522	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	39364552	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61601526	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56626108	usd
CY2023	us-gaap	Revenues Revenues	75893871	usd
CY2022	us-gaap	Revenues Revenues	58953467	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	51012371	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	42383793	usd
CY2023	us-gaap	Gross Profit GrossProfit	24881500	usd
CY2022	us-gaap	Gross Profit GrossProfit	16569674	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26030030	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18075369	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	26030030	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	18075369	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1148530	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1505695	usd
CY2023	us-gaap	Other Income OtherIncome	375063	usd
CY2022	us-gaap	Other Income OtherIncome	112507	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	570387	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	94680	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	269587	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-179120	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1215037	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	28067	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	66507	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1477628	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31449	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-699187	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	35058	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-778441	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18519615	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19202619	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29453206	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19202619	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41611619	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1307362	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	225000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	331417	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3332405	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-778441	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	39364552	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	39364552	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	199913	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50001	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	35058	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	39549522	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	35058	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-778441	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-728000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1506242	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	725398	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	162358	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-178134	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-149326	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	199913	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	331417	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	269587	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-179120	usd
CY2023	strn	Adjustment To Reconcile Operating Lease Expense To Cash Paid AdjustmentToReconcileOperatingLeaseExpenseToCashPaid	10547	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6022938	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5459858	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-228206	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1636772	usd
CY2023	strn	Increase Decrease In Prepaid Tax IncreaseDecreaseInPrepaidTax	-70659	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	565807	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	87473	usd
CY2023	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-806958	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-287084	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	264541	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-931839	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1954649	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-228326	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4538331	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-113019	usd
CY2023	us-gaap	Increase Decrease In Customer Loyalty Program Liability IncreaseDecreaseInCustomerLoyaltyProgramLiability	-5125000	usd
CY2022	us-gaap	Increase Decrease In Customer Loyalty Program Liability IncreaseDecreaseInCustomerLoyaltyProgramLiability	5956122	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-21359	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	258479	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4365089	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2949602	usd
CY2023	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	660340	usd
CY2022	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	737368	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	999362	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	626345	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	414857	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	9965823	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2074559	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11329536	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	775304	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	668731	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50001	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3332405	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1307362	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-825305	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2693774	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7264953	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16972912	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15253756	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32226668	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7988803	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15253756	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	29043	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	85163	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	640789	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	14444	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	626345	usd
CY2022	strn	Non Cash Gap Promotions Asset Acquisition NonCashGAPPromotionsAssetAcquisition	1735000	usd
CY2022	strn	Non Cash Trend Brand Solutions Asset Acquisition NonCashTrendBrandSolutionsAssetAcquisition	1470344	usd
CY2022	strn	Non Cash Premier Asset Acquisition NonCashPremierAssetAcquisition	932600	usd
CY2023	strn	Non Cash Tr Miller Asset Acquisition NonCashTRMillerAssetAcquisition	4551095	usd
CY2023	strn	Reduction In Contingent Earnout Liabilities ReductionInContingentEarnoutLiabilities	654069	usd
CY2022	strn	Reduction In Contingent Earnout Liabilities ReductionInContingentEarnoutLiabilities	140746	usd
CY2023	strn	Reduction In Intangible Asset Associated With Contingent Earnout Liabilities ReductionInIntangibleAssetAssociatedWithContingentEarnoutLiabilities	-654069	usd
CY2022	strn	Reduction In Intangible Asset Associated With Contingent Earnout Liabilities ReductionInIntangibleAssetAssociatedWithContingentEarnoutLiabilities	-140746	usd
CY2023	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1034216	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration of Credit Risk - Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of accounts receivable and deposits in excess of federally insured limits. These risks are managed by performing ongoing credit evaluations of customers’ financial condition and by maintaining all deposits in high quality financial institutions.</span></td></tr></table>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</span></td></tr></table>
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	10495164	usd
CY2023Q4	strn	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	-31365	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	10463799	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	9958475	usd
CY2022Q4	strn	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	-179120	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	9779355	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	317403	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	264160	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6041816	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6557040	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	597542	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	310524	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6639358	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6867564	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3094221	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2094859	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1573288	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1094769	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1000090	usd
CY2023Q4	strn	Cost Of Sale Purchases CostOfSalePurchases	2922066	usd
CY2022Q4	strn	Cost Of Sale Purchases CostOfSalePurchases	3571942	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	1394132	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	479715	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4316198	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4051657	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	7000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	7000000	usd
CY2023	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	0	usd
CY2022	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	0	usd
CY2023	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.05	pure
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5171479	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	633148	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	633148	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	721608	usd
CY2023	strn	Revenue Recognized RevenueRecognized	-75893871	usd
CY2022	strn	Revenue Recognized RevenueRecognized	-58953467	usd
CY2023	strn	Amounts Collected Or Invoiced AmountsCollectedOrInvoiced	80432202	usd
CY2022	strn	Amounts Collected Or Invoiced AmountsCollectedOrInvoiced	58865007	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	5171479	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	633148	usd
CY2023Q4	strn	Reward Program Liability RewardProgramLiability	875000	usd
CY2022Q4	strn	Reward Program Liability RewardProgramLiability	6000000	usd
CY2023	strn	Increase Decrease Value Of Assts Percentage IncreaseDecreaseValueOfAsstsPercentage	0.023	pure
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1335653	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	784683	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	527548	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	324594	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	797558	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	460089	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1325106	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	784683	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	557687	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	466895	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	569236	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	387618	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	188981	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	192672	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	64784	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1403291	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	78185	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1325106	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M26D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2021Q4	strn	Number Of Shares Issued Per Unit NumberOfSharesIssuedPerUnit	1	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4478134	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4478134	shares
CY2021Q4	strn	Outstanding Voting Stock Percentage OutstandingVotingStockPercentage	0.654	pure
CY2022Q1	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	1
CY2022Q1	us-gaap	Treasury Stock Value Acquired Par Value Method TreasuryStockValueAcquiredParValueMethod	10000000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	199913	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	334676	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0386	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2924	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1587000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.15
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3045700	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	68000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.8
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	97000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.11
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1558000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.15
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	453918	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.16
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1558000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.15
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	109500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.54
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	45000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.11
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1622500	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.96
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	859396	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.09
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	35058	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18519615	shares
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-778441	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19202619	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	35058	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29453206	shares
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-778441	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19202619	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	18040	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	48282	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-532700	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	18040	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-484418	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	13409	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-19469	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-195300	usd
CY2023	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	13409	usd
CY2022	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-214769	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31449	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-699187	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3154000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3154000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	841000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	841000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	418206	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	375162	usd
CY2023Q4	strn	Note Payable Wildman NotePayableWildman		usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	strn	Adjustment To Reconcile Operating Lease Expense To Cash Paid AdjustmentToReconcileOperatingLeaseExpenseToCashPaid		usd
CY2022	strn	Increase Decrease In Prepaid Tax IncreaseDecreaseInPrepaidTax		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1		usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1		usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1		usd
CY2023	strn	Non Cash Gap Promotions Asset Acquisition NonCashGAPPromotionsAssetAcquisition		usd
CY2023	strn	Non Cash Trend Brand Solutions Asset Acquisition NonCashTrendBrandSolutionsAssetAcquisition		usd
CY2023	strn	Non Cash Premier Asset Acquisition NonCashPremierAssetAcquisition		usd
CY2022	strn	Non Cash Tr Miller Asset Acquisition NonCashTRMillerAssetAcquisition		usd
CY2023	strn	Total Noncash Investing And Financing Transactions TotalNoncashInvestingAndFinancingTransactions		usd
CY2022	strn	Total Noncash Investing And Financing Transactions TotalNoncashInvestingAndFinancingTransactions		usd
CY2022	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred		usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1520933	usd
CY2022	strn	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue		usd
CY2022	strn	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Expiredand Other Adjustments Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorExpiredandOtherAdjustmentsIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023	strn	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue		usd
CY2023	strn	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Expiredand Other Adjustments Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorExpiredandOtherAdjustmentsIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001872525

Files In Submission

Name	View Source	Status
0001213900-24-027282-index-headers.html	Edgar Link	pending
0001213900-24-027282-index.html	Edgar Link	pending
0001213900-24-027282.txt	Edgar Link	pending
0001213900-24-027282-xbrl.zip	Edgar Link	pending
ea0202559-10k_stran.htm	Edgar Link	pending
ea020255901ex10-14_stran.htm	Edgar Link	pending
ea020255901ex10-41_stran.htm	Edgar Link	pending
ea020255901ex10-42_stran.htm	Edgar Link	pending
ea020255901ex23-1_stran.htm	Edgar Link	pending
ea020255901ex31-1_stran.htm	Edgar Link	pending
ea020255901ex31-2_stran.htm	Edgar Link	pending
ea020255901ex32-1_stran.htm	Edgar Link	pending
ea020255901ex32-2_stran.htm	Edgar Link	pending
ea020255901ex4-1_stran.htm	Edgar Link	pending
ea020255901ex97-1_stran.htm	Edgar Link	pending
ea020255901ex99-1_stran.htm	Edgar Link	pending
ex10-41_001.jpg	Edgar Link	pending
ex10-41_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
ea0202559-10k_stran_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
strn-20231231.xsd	Edgar Link	pending
strn-20231231_def.xml	Edgar Link	unprocessable
strn-20231231_lab.xml	Edgar Link	unprocessable
strn-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
strn-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SWAG
Stran & Company, Inc. Stock $swag

2024 Q1 Form 10-K Financial Statement

#000121390024027282 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWAG Stran & Company, Inc. Stock $swag

2024 Q1 Form 10-K Financial Statement

#000121390024027282 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWAG
Stran & Company, Inc. Stock $swag